Posted inBusiness Obesity drug developer Aardvark files for IPO Posted by admin January 24, 2025No Comments [ad_1] Obesity drug developer Aardvark files for IPO [ad_2] admin View All Posts Post navigation Previous Post 1st Colonial Bancorp announces stock repurchase programNext PostInternational Paper wins EU approval for DS Smith acquisition